Back to ZYME overview

ZYME Zymeworks PE ratio, current and historical analysis

The current price-to-earnings ratio of ZYME can't be determined, as the TTM EPS of -$1.78 is negative. The most recent PE ratio recorded for Zymeworks was 1.96 in September 2023.

ZYME PE ratio history

How has ZYME's PE ratio performed in the past

Over the last six years, the average PE ratio of Zymeworks has been 65.27. In the past six years, ZYME's PE ratio reached its highest point in the Sep 2018 quarter at 314, with a price of $15.7 and an EPS of $0.05. The Sep 2023 quarter saw the lowest point at 1.96, with a price of $6.34 and an EPS of $3.24.

Average
65.27
Median
3.32
Minimum
1.96
Maximum
314

Zymeworks PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 4.12 N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

ZYME average PE ratio chart

What is the average PE ratio of ZYME for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

ZYME PE vs peers

What is ZYME's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $640.16M
OMER Omeros Corp N/A $229.46M
OMGA Omega Therapeutics Inc N/A $117.48M
ZYME Zymeworks Inc N/A $598.87M

Frequently asked questions

What is Zymeworks's PE ratio?

The current price to earnings ratio of ZYME can't be calculated, as its EPS of -$1.78 is negative.

What is the highest PE ratio for ZYME?

Over the last six years, the quarterly PE ratio reached a historic high of 314 in the Sep 2018 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.